World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   26 records for 9 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1
Recruitment statusMain ID Public TitleDate of Registration
Not RecruitingISRCTN89664974
Analysis of Pediatric Pancreatitis -APPLE trial
12/02/2015
RecruitingISRCTN35618458
Pain IN EArly phase of Pediatric Pancreatitis (PINEAPPLE) trial
12/02/2015
RecruitingNCT01712438
Human-cl-rhFVIII in Previously Untreated Patients
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2012-002554-23-ESThe ability to induce an immune response, efficacy and safety of treatment with Human-cl rhFVIII in previously Untreated Patients ,affected by inherited gender-related coagulation disorder ,in which affected males do not produce functional coagulation factor VIII (FVIII) in sufficient quantities to achieve satisfactory blood clotting.06/03/2013
AuthorisedEUCTR2012-002554-23-FRThe ability to induce an immune response, efficacy and safety of treatment with Human-cl rhFVIII in previously Untreated Patients ,affected by inherited gender-related coagulation disorder ,in which affected males do not produce functional coagulation factor VIII (FVIII) in sufficient quantities to achieve satisfactory blood clotting.02/04/2014
RecruitingISRCTN50040185NuProtect: Immunogenicity, efficacy and safety of treatment with Human-cl rhFVIII in previously untreated patients with severe haemophilia A22/10/2013
AuthorisedEUCTR2012-002554-23-GBThe ability to induce an immune response, efficacy and safety of treatment with Human-cl rhFVIII in previously Untreated Patients ,affected by inherited gender-related coagulation disorder ,in which affected males do not produce functional coagulation factor VIII (FVIII) in sufficient quantities to achieve satisfactory blood clotting.13/02/2013
AuthorisedEUCTR2012-002554-23-HRThe ability to induce an immune response, efficacy and safety of treatment with Human-cl rhFVIII in previously Untreated Patients ,affected by inherited gender-related coagulation disorder ,in which affected males do not produce functional coagulation factor VIII (FVIII) in sufficient quantities to achieve satisfactory blood clotting.01/10/2015
AuthorisedEUCTR2012-002554-23-DEThe ability to induce an immune response, efficacy and safety of treatment with Human-cl rhFVIII in previously Untreated Patients ,affected by inherited gender-related coagulation disorder ,in which affected males do not produce functional coagulation factor VIII (FVIII) in sufficient quantities to achieve satisfactory blood clotting.26/02/2013
AuthorisedEUCTR2012-002554-23-SIThe ability to induce an immune response, efficacy and safety of treatment with Human-cl rhFVIII in previously Untreated Patients ,affected by inherited gender-related coagulation disorder ,in which affected males do not produce functional coagulation factor VIII (FVIII) in sufficient quantities to achieve satisfactory blood clotting.08/12/2014
AuthorisedEUCTR2012-002554-23-PTThe ability to induce an immune response, efficacy and safety of treatment with Human-cl rhFVIII in previously Untreated Patients ,affected by inherited gender-related coagulation disorder ,in which affected males do not produce functional coagulation factor VIII (FVIII) in sufficient quantities to achieve satisfactory blood clotting.30/07/2014
Not RecruitingCTRI/2013/09/003958A clinical trial to study Immunogenicity, Efficacy and Safety of Treatment with Human-cl rhFVIII in Previously Untreated Patients with Severe Haemophilia A05-09-2013
18/10/2012
Not RecruitingISRCTN08063129
Efficacy and safety of XM01 compared to placebo in patients with solid tumours or non-myeloid haematological tumours receiving non-platinum chemotherapy
15/09/2010
Not RecruitingISRCTN80501908
Evaluation of IDX375 in healthy and hepatitis C-infected subjects
26/08/2010
Not RecruitingISRCTN09530309
Efficacy and safety of XM01 compared to placebo and Epoetin beta in patients with solid tumours receiving platinum-containing chemotherapy
19/02/2010
Not RecruitingEUCTR2006-006246-34-LV
Evaluation of the anti-anginal efficacy and safety of oral administration of ivabradine compared to placebo on top of a background therapy with a calcium antagonist (amlodipine or nifedipine) in patients with stable angina pectoris: A 6-week, randomised, double-blind, parallel-group, international, multicentre study
Recruitment statusMain IDPublic titleDate of registration
Not RecruitingEUCTR2006-006246-34-HU 06/11/2007
Not RecruitingEUCTR2006-006246-34-PLEvaluation of the anti-anginal efficacy and safety of oral administration of ivabradine compared to placebo on top of a background therapy with a calcium antagonist (amlodipine or nifedipine) in patients with stable angina pectoris. A 6-week randomised double-blind parallel-group international multicentre study.03/04/2008
Not RecruitingEUCTR2006-006246-34-LTEvaluation of the anti-anginal efficacy and safety of oral administration of ivabradine compared to placebo on top of a background therapy with a calcium antagonist (amlodipine or nifedipine) in patients with stable angina pectoris: A 6-week, randomised, double-blind, parallel-group, international, multicentre study29/10/2007
Not RecruitingEUCTR2006-006246-34-EEEvaluation of the anti-anginal efficacy and safety of oral administration of ivabradine compared to placebo on top of a background therapy with a calcium antagonist (amlodipine or nifedipine) in patients with stable angina pectoris. A 6-week randomised double-blind parallel-group international multicentre study.31/10/2007
Not RecruitingEUCTR2006-006246-34-BGEvaluation of the anti-anginal efficacy and safety of oral administration of ivabradine compared to placebo on top of a background therapy with a calcium antagonist (amlodipine or nifedipine) in patients with stable angina pectoris. A 6-week randomised double-blind, parallel-group international, multicentre study.26/06/2008
Not RecruitingISRCTN18979472Evaluation of the anti-anginal efficacy and safety of oral administration of ivabradine compared to placebo on top of a background therapy with a calcium antagonist (amlodipine or nifedipine) in patients with stable angina pectoris: A 6-week, randomised, double-blind, parallel-group, international, multicentre study18/07/2008
09/10/2007
Not recruitingNCT00097669
VITATOPS: A Study of VITAmins TO Prevent Stroke 24/11/2004
Not RecruitingISRCTN74743444
A multi-centre, randomised, double-blind, placebo controlled clinical trial examining the efficiency and safety of multi-vitamin therapy in secondary stroke prevention
Recruitment statusMain IDPublic titleDate of registration
Not recruitingNCT00097669VITATOPS: A Study of VITAmins TO Prevent Stroke24/11/2004
22/05/2003
    
1
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history